1,095 results on '"Dreicer, Robert"'
Search Results
152. New mitomycin formulation for low-grade upper tract urothelial cancer
153. Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: Results of cohort 6 of the COSMIC-021 study.
154. HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer
155. Cabozantinib (C) in combination with atezolizumab (A) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Results of Cohort 6 of the COSMIC-021 Study.
156. A multicenter phase IIb trial to evaluate the efficacy and tolerability of ModraDoc006/r in subjects with metastatic castration-resistant prostate cancer (mCRPC), suitable for treatment with a taxane (NCT04028388).
157. Analysis of clinical outcomes according to response status in prospective clinical trials of atezolizumab (atezo) in pretreated locally advanced/metastatic urothelial carcinoma (mUC).
158. FIGHT-205: Phase II study of first-line pemigatinib (PEMI) plus pembrolizumab (PEMBRO) versus PEMI alone versus standard of care (SOC) for cisplatin (CIS)—Ineligible urothelial carcinoma (UC) with FGFR3 mutation or rearrangement.
159. Real-world practice patterns in veterans with metastatic castration-resistant prostate cancer
160. Sorafenib in patients with metastatic renal cell carcinoma refractory to either sunitinib or bevacizumab
161. Association of percentage of tumour burden removed with debulking nephrectomy and progression-free survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy
162. Metastatic Hormone-Sensitive Prostate Cancer: Clinical Decision Making in a Rapidly Evolving Landscape of Life-Prolonging Therapy
163. Chronic Kidney Disease After Nephroureterectomy for Upper Tract Urothelial Carcinoma and Implications for the Administration of Perioperative Chemotherapy
164. METASTASECTOMY FOLLOWING TARGETED THERAPY IN PATIENTS WITH RENAL CELL CARCINOMA: 1658
165. Inhibiting the Proteasome in Advanced Prostate Cancer
166. Genitourinary Oncology
167. Phase 2 trial of sorafenib in patients with advanced urothelial cancer: A Trial of the Eastern Cooperative Oncology Group
168. Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder: A contemporary series
169. Response of the Primary Tumor to Neoadjuvant Sunitinib in Patients With Advanced Renal Cell Carcinoma
170. Phase II trial of GM-CSF + thalidomide in patients with androgen-independent metastatic prostate cancer
171. Sunitinib-Induced Macrocytosis in Patients With Metastatic Renal Cell Carcinoma
172. Advanced Bladder Cancer: So Many Drugs, So Little Progress: WhatʼS Wrong With This Picture?
173. Phase 2 Trial of Pemetrexed Disodium and Gemcitabine in Advanced Urothelial Cancer (E4802): A Trial of the Eastern Cooperative Oncology Group
174. GENE EXPRESSION PROFILING FOR THE PREDICTION OF THERAPEUTIC RESPONSE TO ADJUVANT DOCETAXEL FOR HIGH RISK LOCALIZED PROSTATE CARCINOMA: 134
175. Presentation, location and overall survival of pelvic recurrence after radical cystectomy for transitional cell carcinoma of the bladder
176. A Model That Predicts the Probability of Positive Imaging in Prostate Cancer Cases With Biochemical Failure After Initial Definitive Local Therapy
177. The Clinical Management of Prostate Cancer — The Medical Oncologist's Approach and Outcomes
178. Neoadjuvant docetaxel treatment for locally advanced prostate cancer: A clinicopathologic study
179. Phase 2 trial of epothilone B analog BMS-247550 (ixabepilone) in advanced carcinoma of the urothelium (E3800): A trial of the eastern cooperative oncology group
180. Hypothyroidism in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
181. Systemic Chemotherapy for Advanced Bladder Cancer: Update and Controversies
182. Phase II study of lenalidomide in patients with metastatic renal cell carcinoma
183. Southwest oncology group phase II study of arsenic trioxide in patients with refractory germ cell malignancies
184. Phase I/II Trial of Bortezomib plus Docetaxel in Patients with Advanced Androgen-Independent Prostate Cancer
185. Adjuvant and neoadjuvant chemotherapy for bladder cancer: management and controversies
186. Society of Urologic Oncology position statement: Redefining the management of hormone-refractory prostate carcinoma
187. Phase I/II Trials of Single-Agent Bortezomib in Androgen-Independent Prostate Cancer
188. Appetite and Cancer-Associated Anorexia: A Review
189. P-261 - Targeted 212Pb therapy in prostate cancer xenograft mouse model using a novel clinical-stage human monoclonal antibody
190. Revisiting Truth and Consequences: What to Do When the Patient Doesn’t Want to Know
191. Preoperative Combined Nested Reverse Transcriptase Polymerase Chain Reaction for Prostate-Specific Antigen and Prostate-Specific Membrane Antigen Does Not Correlate With Pathologic Stage or Biochemical Failure in Patients With Localized Prostate Cancer Undergoing Radical Prostatectomy
192. Phase II trial of gemcitabine and docetaxel in patients with advanced carcinoma of the urothelium: a trial of the Eastern Cooperative Oncology Group
193. Overview of advanced urothelial cancer trials of the Eastern Cooperative Oncology Group
194. Phase II study of paclitaxel plus carboplatin in patients with advanced carcinoma of the urothelium and renal dysfunction (E2896)
195. Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases: a double-blind, randomized dose-response study
196. Phase II Study of Cisplatin and Paclitaxel in Advanced Carcinoma of the Urothelium: An Eastern Cooperative Oncology Group Study
197. EDITORIAL COMMENT
198. Evolving Role of Genomics in Genitourinary Neoplasms
199. Phase II trial of continuous treatment with sunitinib in patients with high-risk (BCG-refractory) non-muscle invasive bladder cancer
200. Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain Endpoint
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.